Drug Development Perspective on Pharmacokinetic Studies of New Drugs in Patients With Renal Impairment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference19 articles.
1. Prevalence of Chronic Kidney Disease in the United States
2. Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
3. Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration?;Int. Journal of Clinical Pharmacology and Therapeutics;2024-03-01
2. Combining pharmacokinetic and electrophysiological models for early prediction of drug-induced arrhythmogenicity;Computer Methods and Programs in Biomedicine;2023-12
3. Estimated glomerular filtration rates are higher when creatinine‐based equations are compared with a cystatin C‐based equation in coronavirus disease 2019;Acta Anaesthesiologica Scandinavica;2022-11-26
4. Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis;The Journal of Clinical Pharmacology;2021-01-18
5. Dose, dosage regimen, and dose adjustment in organ failure;Biopharmaceutics and Pharmacokinetics Considerations;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3